Legend Biotech Corp
NASDAQ:LEGN
Income Statement
Earnings Waterfall
Legend Biotech Corp
Revenue
|
285.1m
USD
|
Cost of Revenue
|
-144.2m
USD
|
Gross Profit
|
140.9m
USD
|
Operating Expenses
|
-668.9m
USD
|
Operating Income
|
-528m
USD
|
Other Expenses
|
9.7m
USD
|
Net Income
|
-518.3m
USD
|
Income Statement
Legend Biotech Corp
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||
Revenue |
60
N/A
|
61
+2%
|
63
+2%
|
57
-9%
|
75
+31%
|
77
+3%
|
86
+11%
|
91
+6%
|
69
-24%
|
105
+53%
|
97
-8%
|
48
-50%
|
110
+127%
|
206
+88%
|
285
+39%
|
|
Gross Profit | ||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(17)
|
(53)
|
(68)
|
(112)
|
(144)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
50
N/A
|
45
-10%
|
(4)
N/A
|
41
N/A
|
94
+127%
|
141
+50%
|
|
Operating Income | ||||||||||||||||
Operating Expenses |
(194)
|
(227)
|
(335)
|
(366)
|
(385)
|
(420)
|
(382)
|
(407)
|
(463)
|
(485)
|
(490)
|
(239)
|
(270)
|
(415)
|
(669)
|
|
Selling, General & Administrative |
(32)
|
(38)
|
(46)
|
(55)
|
(73)
|
(85)
|
(97)
|
(113)
|
(150)
|
(161)
|
(181)
|
(86)
|
(89)
|
(139)
|
(201)
|
|
Research & Development |
(162)
|
(189)
|
(210)
|
(231)
|
(232)
|
(255)
|
(285)
|
(294)
|
(313)
|
(324)
|
(309)
|
(154)
|
(181)
|
(277)
|
(382)
|
|
Other Operating Expenses |
0
|
0
|
(80)
|
(80)
|
(80)
|
(80)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(86)
|
|
Operating Income |
(134)
N/A
|
(166)
-23%
|
(273)
-64%
|
(309)
-13%
|
(310)
0%
|
(343)
-11%
|
(296)
+14%
|
(316)
-7%
|
(394)
-25%
|
(380)
+4%
|
(410)
-8%
|
(244)
+41%
|
(229)
+6%
|
(321)
-40%
|
(528)
-64%
|
|
Pre-Tax Income | ||||||||||||||||
Interest Income Expense |
5
|
(3)
|
(3)
|
(3)
|
3
|
(0)
|
(2)
|
(38)
|
(6)
|
27
|
(39)
|
(53)
|
(96)
|
(102)
|
(19)
|
|
Total Other Income |
2
|
6
|
6
|
3
|
(1)
|
2
|
(1)
|
(3)
|
(7)
|
(5)
|
(10)
|
(9)
|
14
|
50
|
27
|
|
Pre-Tax Income |
(127)
N/A
|
(163)
-28%
|
(269)
-65%
|
(309)
-15%
|
(308)
+0%
|
(341)
-11%
|
(299)
+13%
|
(356)
-19%
|
(407)
-14%
|
(358)
+12%
|
(459)
-28%
|
(305)
+34%
|
(311)
-2%
|
(373)
-20%
|
(520)
-39%
|
|
Net Income | ||||||||||||||||
Tax Provision |
26
|
29
|
30
|
30
|
42
|
38
|
38
|
38
|
4
|
3
|
3
|
(0)
|
(0)
|
(0)
|
2
|
|
Income from Continuing Operations |
(102)
|
(133)
|
(239)
|
(278)
|
(266)
|
(303)
|
(260)
|
(319)
|
(404)
|
(355)
|
(456)
|
(305)
|
(311)
|
(373)
|
(518)
|
|
Net Income (Common) |
(102)
N/A
|
(133)
-31%
|
(239)
-80%
|
(278)
-16%
|
(266)
+4%
|
(303)
-14%
|
(260)
+14%
|
(319)
-22%
|
(404)
-27%
|
(355)
+12%
|
(456)
-28%
|
(305)
+33%
|
(311)
-2%
|
(373)
-20%
|
(518)
-39%
|
|
EPS (Diluted) |
-0.51
N/A
|
-0.51
N/A
|
-0.92
-80%
|
-1.05
-14%
|
-1.13
-8%
|
-1.15
-2%
|
-0.85
+26%
|
-1.09
-28%
|
-1.43
-31%
|
-1.14
+20%
|
-1.47
-29%
|
-0.92
+37%
|
-0.88
+4%
|
-1.02
-16%
|
-1.47
-44%
|